search
Back to results

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)

Primary Purpose

HIV, Tuberculosis, Pediatrics

Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Development of a diagnosis algorithm
Sponsored by
ANRS, Emerging Infectious Diseases
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for HIV focused on measuring HIV, Tuberculosis, Diagnosis, Pediatrics, Asia, Africa

Eligibility Criteria

undefined - 13 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • children aged from 0 to 13 years
  • confirmed HIV infection
  • suspicion of tuberculosis
  • informed consent signed by at least one parent or guardian
  • on ARVs or not

Exclusion Criteria:

  • history of anti TB treatment started in the past 2 years
  • on going tuberculosis treatment
  • Suspicion of exclusive extra-thoracic tuberculosis

Sites / Locations

  • CHU Sourô Sanou
  • National Pediatric Hospital
  • Angkor Hospital for Children
  • Centre Hospitalier d'Essos
  • Centre Mère Enfant Chantal Biya
  • Pediatric Hospital Nhi Dong 1
  • Pediatric Hospital Nhi Dong 2
  • Pham Ngoc Thach Hospital

Outcomes

Primary Outcome Measures

Tuberculosis diagnostic algorithm
Development of an effective diagnostic algorithm for pediatric tuberculosis after evaluating the following diagnostic tests and sampling methods: Clinical examination Chest X-rays Abdominal ultrasound IGRAs Xpert MTB/RIF Gastric aspirate String test Nasopharyngeal aspirate Stools sample Sputum samples

Secondary Outcome Measures

Evaluation of the QuantiFERON(R)-TB Gold In-Tube
Evaluation of the sensitivity, specificity, positive and negative predictive values of an in-vitro Interferon Gamma Release (IGRAs) : the QuantiFERON(R)-TB Gold iIn-Tube, for the diagnosis of TB in HIV infected children
Comparison of two in-vitro IGRAs
Comparison of the performances of two in-vitro IGRAs: the QauntiFERON(R)-TB Gold In-Tube and the T.SPOT-TB(R), for the diagnosis of tuberculosis in a sub-group of HIV infected children.
Percentage of TB diagnosis sampling procedures actually performed
To assess the feasibility of the following TB sampling procedures: the string test the nasopharyngeal aspirate stool sample
Evaluation of the morbidity (IRIS, drug toxicity and other opportunistic infections) and mortality in TB-HIV co-infected children
Specificity and sensibility of TB diagnosis sampling procedures compared to TB diagnosis gold standard (sputum or gastric aspirate culture)
To assess the performance of the following TB sampling procedures: the string test the nasopharyngeal aspirate stools sample
Evaluation of the Xpert MTB/RIF assay
Evaluate the sensitivity, specificity, positive and negative predictive values of the Xpert MTB/RIF assay
Comparison of the Xpert MTB/RIF test to the gold standard (culture of gastric aspirates or sputum)
Comparison of the performance Xpert MTB/RIF assay on sampling methods other than the reference method (gastric aspirate and sputum)
Evaluation of the Xpert MTB/RIF assay on the following sampling methods: String test Nasopharyngeal aspirates Stool samples

Full Information

First Posted
April 4, 2011
Last Updated
August 4, 2015
Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
Institut Pasteur, Cambodia, National Pediatric Hospital, Cambodia, Angkor Hospital for Children, Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam, Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam, Number 2 Children's Hospital, Ho Chi Minh City, Hôpital Necker-Enfants Malades, Paris, France, Groupe Hospitalier Pitie-Salpetriere, CHRU Arnaud de Villeveuve, Montpellier, France, IRD, Yaounde, Cameroon, Fondation Chantal Biya,Yaounde, Cameroon, CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso, Centre Muraz, Centre Pasteur du Cameroun, Centre Hospitalier D'essos
search

1. Study Identification

Unique Protocol Identification Number
NCT01331811
Brief Title
Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)
Official Title
Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam) and Africa (Burkina Faso, Cameroon) ANRS 12229 PAANTHER 01 (Pediatric Asian African Network for Tuberculosis and HIV Research)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2015
Overall Recruitment Status
Completed
Study Start Date
April 2011 (undefined)
Primary Completion Date
March 2014 (Actual)
Study Completion Date
May 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ANRS, Emerging Infectious Diseases
Collaborators
Institut Pasteur, Cambodia, National Pediatric Hospital, Cambodia, Angkor Hospital for Children, Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam, Pediatric Hospital Nhi Dong 1, Ho Chi Minh City, Vietnam, Number 2 Children's Hospital, Ho Chi Minh City, Hôpital Necker-Enfants Malades, Paris, France, Groupe Hospitalier Pitie-Salpetriere, CHRU Arnaud de Villeveuve, Montpellier, France, IRD, Yaounde, Cameroon, Fondation Chantal Biya,Yaounde, Cameroon, CHU Sourô Sanou, Bobo Dioulasso, Burkina Faso, Centre Muraz, Centre Pasteur du Cameroun, Centre Hospitalier D'essos

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Childhood tuberculosis (TB) accounts for 11% of the total 9 million annual TB cases and the difficulty of its diagnosis is increased in case of HIV infection in children. The aim of this study is to improve TB diagnosis in HIV-infected children by developing a new diagnostic algorithm incorporating new tools available such as: interferon gamma release assays (IGRAs), as alternative to the tuberculin skin test alternative specimen collection methods such as string test (or Enterotest (R)), nasopharyngeal aspirates and stools samples, as alternatives to gastric aspirate the Xpert MTB/RIF assay

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV, Tuberculosis, Pediatrics
Keywords
HIV, Tuberculosis, Diagnosis, Pediatrics, Asia, Africa

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
441 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
Development of a diagnosis algorithm
Intervention Description
At entry in the study, HIV infected children with suspected tuberculosis will undergo a complete evaluation including: interview on anamnesis clinical examination evaluation of HIV infection stage hematology and biochemistry tests CD4 count HIV viral load IGRA chest radiograph Abdominal ultrasonograph to detect abdominal lymphadenopathy Tuberculin skin test gastric aspirates, sputum and string tests according to the age of children nasopharyngeal aspirate stool sample lymph node fine needle aspirate or other specimen collection if applicable Diagnosis and treatment of all participating children will be done according to national guidelines. The children will be followed-up for 6 months until the end of their anti-TB treatment. For the analysis of data and the validation of the algorithm, children will be randomized into 2 groups. Data from Group I will be used to develop the algorithm; data from Group II will be used to validate it.
Primary Outcome Measure Information:
Title
Tuberculosis diagnostic algorithm
Description
Development of an effective diagnostic algorithm for pediatric tuberculosis after evaluating the following diagnostic tests and sampling methods: Clinical examination Chest X-rays Abdominal ultrasound IGRAs Xpert MTB/RIF Gastric aspirate String test Nasopharyngeal aspirate Stools sample Sputum samples
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Evaluation of the QuantiFERON(R)-TB Gold In-Tube
Description
Evaluation of the sensitivity, specificity, positive and negative predictive values of an in-vitro Interferon Gamma Release (IGRAs) : the QuantiFERON(R)-TB Gold iIn-Tube, for the diagnosis of TB in HIV infected children
Time Frame
6 months
Title
Comparison of two in-vitro IGRAs
Description
Comparison of the performances of two in-vitro IGRAs: the QauntiFERON(R)-TB Gold In-Tube and the T.SPOT-TB(R), for the diagnosis of tuberculosis in a sub-group of HIV infected children.
Time Frame
6 months
Title
Percentage of TB diagnosis sampling procedures actually performed
Description
To assess the feasibility of the following TB sampling procedures: the string test the nasopharyngeal aspirate stool sample
Time Frame
6 months
Title
Evaluation of the morbidity (IRIS, drug toxicity and other opportunistic infections) and mortality in TB-HIV co-infected children
Time Frame
at 6 month of TB treatment
Title
Specificity and sensibility of TB diagnosis sampling procedures compared to TB diagnosis gold standard (sputum or gastric aspirate culture)
Description
To assess the performance of the following TB sampling procedures: the string test the nasopharyngeal aspirate stools sample
Time Frame
6 months
Title
Evaluation of the Xpert MTB/RIF assay
Description
Evaluate the sensitivity, specificity, positive and negative predictive values of the Xpert MTB/RIF assay
Time Frame
6 months
Title
Comparison of the Xpert MTB/RIF test to the gold standard (culture of gastric aspirates or sputum)
Time Frame
6 months
Title
Comparison of the performance Xpert MTB/RIF assay on sampling methods other than the reference method (gastric aspirate and sputum)
Description
Evaluation of the Xpert MTB/RIF assay on the following sampling methods: String test Nasopharyngeal aspirates Stool samples
Time Frame
6 months

10. Eligibility

Sex
All
Maximum Age & Unit of Time
13 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: children aged from 0 to 13 years confirmed HIV infection suspicion of tuberculosis informed consent signed by at least one parent or guardian on ARVs or not Exclusion Criteria: history of anti TB treatment started in the past 2 years on going tuberculosis treatment Suspicion of exclusive extra-thoracic tuberculosis
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Olivier Marcy, MD
Organizational Affiliation
Institut Pasteur in Cambodia, Phnom Penh, Cambodia
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Vibol Ung, MD
Organizational Affiliation
National Pediatric Hospital, Phnom Penh, Cambodia
Official's Role
Study Chair
Facility Information:
Facility Name
CHU Sourô Sanou
City
Bobo Dioulasso
Country
Burkina Faso
Facility Name
National Pediatric Hospital
City
Phnom Penh
Country
Cambodia
Facility Name
Angkor Hospital for Children
City
Siem Reap
Country
Cambodia
Facility Name
Centre Hospitalier d'Essos
City
Yaounde
Country
Cameroon
Facility Name
Centre Mère Enfant Chantal Biya
City
Yaounde
Country
Cameroon
Facility Name
Pediatric Hospital Nhi Dong 1
City
Ho Chi Minh City
Country
Vietnam
Facility Name
Pediatric Hospital Nhi Dong 2
City
Ho Chi Minh City
Country
Vietnam
Facility Name
Pham Ngoc Thach Hospital
City
Ho chi Minh ville
Country
Vietnam

12. IPD Sharing Statement

Citations:
PubMed Identifier
31455612
Citation
Marcy O, Borand L, Ung V, Msellati P, Tejiokem M, Huu KT, Do Chau V, Ngoc Tran D, Ateba-Ndongo F, Tetang-Ndiang S, Nacro B, Sanogo B, Neou L, Goyet S, Dim B, Pean P, Quillet C, Fournier I, Berteloot L, Carcelain G, Godreuil S, Blanche S, Delacourt C; ANRS 12229 PAANTHER 01 STUDY GROUP. A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis. Pediatrics. 2019 Sep;144(3):e20182065. doi: 10.1542/peds.2018-2065.
Results Reference
derived
PubMed Identifier
30689814
Citation
Borand L, de Lauzanne A, Nguyen NL, Cheng S, Pham TH, Eyangoh S, Ouedraogo AS, Ung V, Msellati P, Tejiokem M, Nacro B, Inghammar M, Dim B, Delacourt C, Godreuil S, Blanche S, Marcy O; Pediatric Asian African Network for Tuberculosis and HIV Research (PAANTHER) Study Group. Isolation of Nontuberculous Mycobacteria in Southeast Asian and African Human Immunodeficiency Virus-infected Children With Suspected Tuberculosis. Clin Infect Dis. 2019 May 2;68(10):1750-1753. doi: 10.1093/cid/ciy897.
Results Reference
derived
PubMed Identifier
29174612
Citation
Marcy O, Tejiokem M, Msellati P, Truong Huu K, Do Chau V, Tran Ngoc D, Nacro B, Ateba-Ndongo F, Tetang-Ndiang S, Ung V, Dim B, Neou L, Berteloot L, Borand L, Delacourt C, Blanche S; ANRS 12229 PAANTHER 01 Study Group. Mortality and its determinants in antiretroviral treatment-naive HIV-infected children with suspected tuberculosis: an observational cohort study. Lancet HIV. 2018 Feb;5(2):e87-e95. doi: 10.1016/S2352-3018(17)30206-0. Epub 2017 Nov 23.
Results Reference
derived
PubMed Identifier
26908804
Citation
Marcy O, Ung V, Goyet S, Borand L, Msellati P, Tejiokem M, Nguyen Thi NL, Nacro B, Cheng S, Eyangoh S, Pham TH, Ouedraogo AS, Tarantola A, Godreuil S, Blanche S, Delacourt C. Performance of Xpert MTB/RIF and Alternative Specimen Collection Methods for the Diagnosis of Tuberculosis in HIV-Infected Children. Clin Infect Dis. 2016 May 1;62(9):1161-1168. doi: 10.1093/cid/ciw036. Epub 2016 Feb 7.
Results Reference
derived

Learn more about this trial

Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon)

We'll reach out to this number within 24 hrs